Achievement of Improved Post-Intervention Status in Patients with Generalized Myasthenia Gravis Treated with Ravulizumab during the CHAMPION MG Study

被引：1
|
作者：
Muppidi, Srikanth [1 ]
Narayanaswami, Pushpa [2 ]
Meisel, Andreas [3 ]
Vu, Tuan [4 ]
Utsugisawa, Kimiaki [5 ]
Mantegazza, Renato [6 ]
Beasley, Kathleen [7 ]
Liao, Serena [7 ]
Howard, James [8 ]
机构：
[1] Stanford Univ Sch Med, Stanford, CA USA
[2] Beth Israel Deaconess Med Ctr, Boston, MA USA
[3] Charite Univ Med Berlin, Berlin, Germany
[4] Univ S Florida, Tampa, FL USA
[5] Hanamaki Gen Hosp, Hanamaki, Japan
[6] Fondazione IRCCS Ist Neurol Carlo Besta, Milan, Italy
[7] Alexion, Astra Zeneca Rare Dis, Boston, MA USA
[8] Univ N Carolina, Chapel Hill, NC USA
来源：
NEUROLOGY | 2023年 / 100卷 / 17期
关键词：
D O I：
10.1212/WNL.0000000000202156
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
S5.008
引用
收藏
页数：6
相关论文
共 18 条
  • [1] Efficacy of ravulizumab in patients with generalized myasthenia gravis by time from diagnosis: A post hoc subgroup analysis of the CHAMPION MG study
    Howard Jr, James F.
    Vu, Tuan
    Mantegazza, Renato
    Kushlaf, Hani
    Suzuki, Shigeaki
    Wiendl, Heinz
    Beasley, Kathleen N.
    Liao, Serena
    Meisel, Andreas
    MUSCLE & NERVE, 2024, 69 (05) : 556 - 565
  • [2] CONSISTENT EFFICACY OF RAVULIZUMAB ACROSS SEX AND AGE SUBGROUPS OF PATIENTS WITH GENERALIZED MYASTHENIA GRAVIS: A POST HOC ANALYSIS OF THE CHAMPION MG STUDY
    Juel, Vern
    Vu, Tuan
    Casasnovas, Carlos
    Uzawa, Akiyuki
    Aguzzi, Rasha
    Frick, Glen
    Howard, James F., Jr.
    MUSCLE & NERVE, 2022, 65 : S1 - S2
  • [3] EFFICACY OF RAVULIZUMAB TREATMENT ACCORDING TO TIME FROM DIAGNOSIS IN PATIENTS WITH GENERALIZED MYASTHENIA GRAVIS: A POST HOC SUBGROUP ANALYSIS OF THE CHAMPION MG STUDY
    Howard, James F., Jr.
    Vu, Tuan
    Mantegazza, Renato
    Kushlaf, Hani
    Suzuki, Shigeaki
    Wiendl, Heinz
    Beasley, Kathleen N.
    Liao, Serena
    Meisel, Andreas
    MUSCLE & NERVE, 2022, 65 : S1 - S1
  • [4] Post-intervention Status in Patients With Refractory Myasthenia Gravis Treated With Eculizumab During REGAIN and Its Open-Label Extension
    Mantegazza, Renato
    Wolfe, Gil, I
    Muppidi, Srikanth
    Wiendl, Heinz
    Fujita, Kenji P.
    O'Brien, Fanny L.
    Booth, Heather D. E.
    Howard, James F., Jr.
    NEUROLOGY, 2021, 96 (04) : E610 - E618
  • [5] Ravulizumab in adults with generalised myasthenia gravis: Post hoc analysis of MG-ADL item score change in CHAMPION MG
    Vissing, J.
    Mozaffar, T.
    Mantegazza, R.
    Attarian, S.
    Yoshimura, S.
    Beasley, K.
    Liao, S.
    Pandya, S.
    Howard, J., Jr.
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 211 - 211
  • [6] Ravulizumab in Adults with Generalized Myasthenia Gravis: A Sub-Analysis of the Phase 3 CHAMPION MG Study According to Chronic IVIg Use at Study Entry
    Bril, Vera
    Shin, Jin-Hong
    Silvestri, Nicholas
    Winkley, James
    Gordon, Andrew
    Suzuki, Yasushi
    Aguzzi, Rasha
    Frick, Glen
    NEUROLOGY, 2023, 100 (17)
  • [7] CONCOMITANT CORTICOSTEROID USE WITH RAVULIZUMAB IN ADULTS WITH ANTI-ACETYLCHOLINE RECEPTOR ANTIBODY-POSITIVE GENERALIZED MYASTHENIA GRAVIS: PHASE 3 CHAMPION-MG OPENLABEL EXTENSION FINAL RESULTS
    Nicolle, Michael
    Annane, Djillali
    Meisel, Andreas
    Vu, Tuan
    Mantegazza, Renato
    Katsuno, Masahisa
    Bril, Vera
    Aguzzi, Rasha
    Frick, Glen
    Howard, James F., Jr.
    MUSCLE & NERVE, 2024, 70 (03) : 574 - 575
  • [8] Validation of ME&MG, a novel digital device for patients with generalized myasthenia gravis: the DOMYA Study
    Berling, E.
    Orlikowski, D.
    Nicolas, G.
    Prigent, H.
    N'Dah-Sekou, G.
    Carment, L.
    Gorin, C.
    Klaeyle, L.
    Cuq, E. Toure
    Aras, E.
    Zinai, S.
    Laforet, P.
    NEUROMUSCULAR DISORDERS, 2024, 43
  • [9] Long-term efficacy and safety of ravulizumab in adults with anti-acetylcholine receptor antibody-positive generalized myasthenia gravis: results from the phase 3 CHAMPION MG open-label extension
    Meisel, Andreas
    Annane, Djillali
    Vu, Tuan
    Mantegazza, Renato
    Katsuno, Masahisa
    Aguzzi, Rasha
    Frick, Glen
    Gault, Laura F.
    Howard Jr, James
    JOURNAL OF NEUROLOGY, 2023, 270 (08) : 3862 - 3875
  • [10] Long-term efficacy and safety of ravulizumab in adults with anti-acetylcholine receptor antibody-positive generalized myasthenia gravis: results from the phase 3 CHAMPION MG open-label extension
    Andreas Meisel
    Djillali Annane
    Tuan Vu
    Renato Mantegazza
    Masahisa Katsuno
    Rasha Aguzzi
    Glen Frick
    Laura Gault
    James F. Howard
    Journal of Neurology, 2023, 270 : 3862 - 3875
12